Fan Chen is the founder of TrueBinding. TrueBinding has raised $100M in total funding. Latest round: Seed. Based in Foster City, California.
Fan Chen, PhD, serves as the COO of TrueBinding, a clinical-stage biotherapeutics company. TrueBinding focuses on developing treatments for neurodegeneration, stroke, fibrosis, and oncology by targeting chronic inflammation and age-related decline through its TrueBinding™ platform, which notably neutralizes Galectin-3. Chen brings over 20 years of experience in Bioprocess Development, having held senior leadership positions at AstraZeneca, LakePharma, Dendreon, and MedImmune.
Full founder directory · Investor directory · Company funding database · Fundraising library